94-23135. [No title available]  

  • [Federal Register Volume 59, Number 180 (Monday, September 19, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-23135]
    
    
    [[Page Unknown]]
    
    [Federal Register: September 19, 1994]
    
    
    _______________________________________________________________________
    
    Part IV
    
    
    
    
    
    Office of Management and Budget
    
    
    
    
    
    _______________________________________________________________________
    
    
    
    Cumulative Report on Rescissions and Deferrals; Notice
    OFFICE OF MANAGEMENT AND BUDGET
    
    Cumulative Report on Rescissions and Deferrals
    
    September 1, 1994.
        This report is submitted in fulfillment of the requirement of 
    Section 1014(e) of the Congressional Budget and Impoundment Control Act 
    of 1974 (Public Law 93-344). Section 1014(e) requires a month report 
    listing all budget authority for this fiscal year for which, as of the 
    first day of the month, a special message has been transmitted to 
    Congress.
        This report gives the status of 65 rescission proposals and 12 
    deferrals contained in six special messages for FY 1994. These messages 
    were transmitted to Congress on October 13, November 1, and November 
    19, 1993; and on February 7, May 2, and June 8, 1994.
    
    Rescissions (Attachments A and C)
    
        As of September 1, 1994, 65 rescission proposals totaling $3,172.2 
    million had been transmitted to the Congress. Congress approved 45 of 
    the Administration's rescission proposals in P.L. 103-211. A total of 
    $1,286.7 million of the rescissions proposed by the President was 
    rescinded by that measure. There are no rescission proposals pending 
    before the Congress. Attachment C shows the status of the FY 1994 
    rescission proposals.
    
    Deferrals (Attachments B and D)
    
        As of September 1, 1994, $1,199.6 million in budget authority was 
    being deferred from obligation. Attachment D shows the status of each 
    deferral reported during FY 1994.
    
    Information From Special Messages
    
        The special messages containing information on the rescission 
    proposals and deferrals that are covered by this cumulative report are 
    printed in the Federal Register cited below:
    
    58 FR 54256, Wednesday, October 20, 1993
    58 FR 59517, Tuesday, November 9, 1993
    58 FR 63264, Tuesday, November 30, 1993
    59 FR 7122, Monday, February 14, 1994
    59 FR 24006, Monday, May 9, 1994
    59 FR 32068, Tuesday, June 21, 1994
    Alice M. Rivlin,
    Acting Director.
    
    BILLING CODE 3110-01-M
    
    TN19SE94.082
    
    
    TN19SE94.083
    
    
    TN19SE94.084
    
    
    TN19SE94.085
    
    
    TN19SE94.086
    
    
    TN19SE94.087
    
    
    TN19SE94.088
    
    
    TN19SE94.089
    
    
    TN19SE94.090
    
    
    [FR Doc. 94-23084 Filed 9-16-94; 8:45 am]
    BILLING CODE 3110-01-C
    _______________________________________________________________________
    
    Part VI
    
    
    
    
    
    Department of Health and Human Services
    
    
    
    
    
    _______________________________________________________________________
    
    
    
    National Institutes of Health
    
    
    
    _______________________________________________________________________
    
    
    
    National Institutes of Health Acquired Immunodeficiency Syndrome (AIDS) 
    Research Loan Repayment Program; Notice
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    RIN 0905-ZA59
    
     
    National Institutes of Health Acquired Immunodeficiency Syndrome 
    (AIDS) Research Loan Repayment Program
    
    AGENCY: National Institutes of Health, Public Health Service, HHS
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The National Institutes of Health (NIH) announces the 
    availability of educational loan repayment under the National 
    Institutes of Health Acquired Immunodeficiency Syndrome (AIDS) Research 
    Loan Repayment Program. The Program, which is authorized by section 
    487A of the Public Health Service (PHS) Act (42 U.S.C. 288-1), as added 
    by the Health Omnibus Programs Extension Act of 1988 (Pub. L. 100-607) 
    and amended by the National Institutes of Health Revitalization Act of 
    1993 (Pub. L. 103-43), provides for the partial repayment of the 
    accumulated educational loan debt of health professionals who agree to 
    conduct, as employees of the NIH, research with respect to AIDS. The 
    Program provides for the repayment of up to $20,000 of the principal 
    and interest of the educational loans of such health professionals for 
    each year of obligated service. The purpose of the program is the 
    recruitment and retention of highly qualified health professionals 
    conducting AIDS research as NIH employees. The NIH, through this 
    notice, invites health professionals interested in engaging in AIDS 
    research as NIH employees to apply for participation in the NIH AIDS 
    Research Loan Repayment Program.
    
    DATES: Interested persons may request information about the Program 
    beginning on September 19, 1994.
    
    ADDRESSES: Information regarding the requirements and application 
    procedures for the Program may be obtained by calling or writing: Mr. 
    Marc Horowitz, Director, NIH AIDS Research Loan Repayment Program, 
    Office of AIDS Research, National Institutes of Health, Federal 
    Building, Suite 102, 7550 Wisconsin Avenue, Bethesda, Maryland 20892-
    9905 (1-800-528-7689).
    
    SUPPLEMENTARY INFORMATION: The National Institutes of Health 
    Revitalization Act of 1993 (Public Law 103-43) was enacted on June 10, 
    1993, amending section 487A of the Public Health Service (PHS) Act (42 
    U.S.C. 288-1). Section 487A directs the Secretary to continue a program 
    of entering into agreements with appropriately qualified health 
    professionals under which such health professionals agree to conduct, 
    as employees of the NIH, research with respect to acquired 
    immunodeficiency syndrome (AIDS) in consideration of the Federal 
    Government agreeing to repay, for each year of service, not more than 
    $20,000 of the principal and interest of the educational loans of such 
    health professionals. This program is known as the NIH AIDS Research 
    Loan Repayment Program.
        Under the Program, the NIH will repay qualified educational loan 
    debt incurred by health professionals to pay for their undergraduate, 
    graduate, and/or medical educational expenses. Upon application, 
    individuals must have total qualified debt which will exceed 20% of 
    their anticipated annual NIH salary (``debt threshold'') on the date of 
    program eligibility. Half of this debt threshold amount will not be 
    repaid by the Program and will remain the obligation of the 
    participant.
        The remaining repayable debt of qualified health professionals will 
    be satisfied at the rate of one-third per year, subject to a statutory 
    limit of $20,000 per year, for each year of obligated service EXCEPT 
    for individuals with repayable debt equal to or less than $10,000. 
    These individuals will receive repayment of their repayable debt at the 
    rate of one-half per year. Obligated service requires individuals 
    selected to participate in the Program to agree to serve at least 2 
    years as an NIH employee engaged in qualified AIDS research. 
    Participants may apply for renewal contracts in one-year increments to 
    satisfy their remaining repayable debt.
        In return for the repayment of their educational loans, 
    participants must agree to (1) Engage primarily in qualified AIDS 
    research as employees of the NIH for a minimum period of 2 years; (2) 
    make payments to lenders on their own behalf for periods of Leave 
    Without Pay (LWOP); (3) pay monetary damages as required for breach of 
    contract; and (4) satisfy other terms and conditions of the Program's 
    contract and application procedures. Applicants must submit a signed 
    contract, prepared by the NIH, agreeing to obligated service at the 
    time they apply for consideration under the Program. Substantial 
    monetary penalties will be imposed for breach of contract.
        Since program participation is contingent upon employment with the 
    NIH, an individual who wishes to apply must obtain a written commitment 
    from an Institute, Center, or Division (ICD) Personnel Office of the 
    NIH to be employed in a qualified AIDS research position. Current 
    deadlines, sources for assistance, and additional details regarding 
    application procedures are published in an annual Applicant Information 
    Bulletin which is available from the Director, AIDS Research Loan 
    Repayment Program.
        The Loan Repayment Committee (LRC), whose members are appointed by 
    the Director, NIH, review, rank, and approve or disapprove the 
    scientific portions of Loan Repayment Program applications. The LRC is 
    composed of NIH scientific staff and chaired by the Associate Director 
    for AIDS Research, NIH. Review and selection of applications for 
    approval is based upon the following:
        (1) The appropriateness of the research assignment to qualified 
    AIDS research;
        (2) The scientific merit of the research assignment; and
        (3) The credentials of both applicant and supervisor and other 
    criteria the Secretary deems appropriate.
        Initial contracts will be executed to cover a two-year service 
    period. At the conclusion of this initial contract, participants may be 
    recommended for a one-year renewal contract, subject to review of their 
    AIDS research accomplishments. These continuation contracts may be 
    approved on a year-to-year basis. Funding of all contracts is 
    contingent upon appropriation and/or allocation of funds from the U.S. 
    Congress and/or the NIH.
        The NIH will repay lenders for the principal, interest, and related 
    expenses (such as the required insurance premiums on the unpaid 
    balances of some loans) of qualified Government (Federal, State, local) 
    and commercial educational loans obtained by participants for the 
    following:
        (1) Undergraduate, graduate, and health professional school tuition 
    expenses;
        (2) Other reasonable educational expenses required by the school(s) 
    attended, including fees, books, supplies, educational equipment and 
    materials, and laboratory expenses; and
        (3) Reasonable living expenses, including the cost of room and 
    board, transportation and commuting costs, and other reasonable living 
    expenses as determined by the Secretary.
        Repayments will be authorized quarterly for direct payment to 
    lenders, following receipt of (1) The supervisor's verification of 
    completion of the prior period of obligated service and (2) lender 
    verification of the crediting of prior loan repayments, including the 
    resulting account balances and current account status. The NIH will 
    repay loans in the following order unless significant savings would 
    result from repaying loans in a different priority order:
        (1) Health Education Assistance Loans (HEAL);
        (2) Other loans guaranteed by the Federal Government; and
        (3) Other qualifying loans.
        The following loans are NOT repayable under the Program:
        (1) Loans not obtained from a Government entity or commercial 
    lending institution, such as loans from friends and relatives, or other 
    private individuals;
        (2) Loans for which contemporaneous documentation is not available; 
    and
        (3) Loans, or those portions of loans, obtained for educational or 
    living expenses which exceed a ``reasonable'' level as determined by a 
    review of the standard school budget for the year in which the loan was 
    made.
        In addition, for other programs which provide loans, scholarships, 
    loan repayments, or similar awards in exchange for a future service 
    obligation, the NIH will NOT repay any sums that may result from 
    failure to serve as required or conversion of the obligation to a loan 
    under these programs. This includes, but is not limited to the 
    following:
        (1) Physicians Shortage Area Scholarship Program;
        (2) National Research Service Award Program;
        (3) Public Health Service and National Health Service Corps 
    Scholarship Programs;
        (4) Armed Forces (Army, Navy, or Air Force) Health Professions 
    Scholarship Programs; and
        (5) Indian Health Service Scholarship Program.
        Finally, payments will not be made under the Program for loans 
    which participants have already repaid, delinquent loans, loans in 
    default, loans not current in their payment schedule, or loans for 
    which promissory notes have been signed after the program eligibility 
    date. During lapses in loan repayments, due either to administrative 
    complications or a break in service, Program participants are wholly 
    responsible for making payments or other arrangements which maintain 
    loans in a current payment status such that increases in either 
    principal or interest do not occur. Penalties assessed participants as 
    a result of NIH administrative complications may be considered for 
    reimbursement.
    
    Activities Constituting AIDS Research
    
        The following parameters define whether a proposed research 
    assignment meets the criteria for coverage under the NIH AIDS Research 
    Loan Repayment Program--that is, whether the incumbent will be 
    ``primarily'' engaged in AIDS research. ``Primarily'' engaged in AIDS 
    research is defined as AIDS research activities that constitute at 
    least 80% of a researcher's time. Clinical Associates, whose intent is 
    to primarily engage in AIDS research, must engage in qualified AIDS 
    research for at least three months in the first year of their program, 
    with a total of fifteen months of qualified AIDS research during their 
    two-year contract. AIDS researchers include registered nurses who are 
    principal or associate investigators in AIDS research studies.
        (1) AIDS research includes studies of the human immunodeficiency 
    virus (HIV), the pathophysiology of HIV infection, the development of 
    models of HIV infection and its sequelae, cofactors predisposing to HIV 
    infection and AIDS, or its sequelae, and the development of vaccines 
    and therapeutics. Specifically, the following research activities are 
    included:
        a. Studies of HIV and related retroviruses;
        b. Studies of the mechanism(s) by which HIV and related 
    retroviruses establish infection and infect host cells;
        c. Studies of the mechanism(s) by which HIV and related 
    retroviruses cause disease, including studies of the immune deficiency 
    induced by HIV and related retroviruses;
        d. Studies of the pathophysiology of host response to HIV 
    infection;
        e. Studies of in vivo or in vitro models of human HIV infection and 
    its sequelae;
        f. Epidemiologic studies of HIV and related retrovirus infection;
        g. Clinical trials involving prophylaxis or therapy for HIV 
    infection or its sequelae;
        h. Preclinical studies aimed at the development of therapy for or 
    prevention of HIV infection and the immunodeficiency caused by HIV 
    infection and its sequelae;
        i. Cofactors predisposing to acquiring HIV infection and/or the 
    progression of HIV-related disease;
        j. Basic studies and clinical trials involving vaccines, or other 
    immunological or chemotherapeutic interventions for the prevention of 
    HIV infection and its sequelae;
        k. Studies into the transmission of HIV involving high risk 
    behaviors and research concerning the interruption of transmission by 
    behavioral change and pharmacologic intervention; and
        l. Basic studies of the societal impact of and response to the HIV/
    AIDS epidemic, including subgroups within the population.
        (2) AIDS researchers include scientists who are intellectually 
    engaged in the process of providing scientific direction and guidance 
    in programs of original AIDS research, specifically, epidemiologists, 
    statisticians, and others who are involved in the design and conduct of 
    research studies. The duties of such scientists may include the 
    generation and design of studies and collation and analysis of data; 
    and/or the preparation and publication, as author or co-author, of 
    studies in peer-reviewed journals.
        (3) AIDS researchers include physicians and registered nurses who 
    are providing care for HIV-infected individuals who are subjects of 
    HIV-related research.
    
    Eligibility Criteria
    
        Specific eligibility criteria with regard to participation in the 
    NIH AIDS Research Loan Repayment Program include the following:
        (1) Participants must be U.S. citizens, nationals, or permanent 
    residents;
        (2) Participants must have a Ph.D., M.D., D.O., D.D.S., D.M.D., 
    D.V.M., B.S.N. or A.D.N., or equivalent degree;
        (3) Participants must have qualifying educational debt in excess of 
    20 percent of their annual NIH salary at their expected date of program 
    eligibility. In the case of U.S. Commissioned Corps employees, their 
    NIH salary includes base pay plus quarters, subsistence, and variable 
    housing allowances. Special and bonus pays, such as board certified, 
    contract, and variable incentive pays, are not considered in the LRP's 
    calculation of salary. For those employed under the Civil Service 
    General Schedule, salary does not include Physicians Comparability 
    Allowances (PCAs). However, PCA recipients who are accepted into the 
    LRP will have their PCAs reduced by the amount of loan repayments to be 
    received. The expected date of program eligibility is the date by which 
    the following conditions will be met: (a) An applicant agrees to begin 
    qualified AIDS research as a NIH employee, and (b) the Secretary is 
    expected to execute their LRP contract;
        (4) Participants must be considered employees of the NIH. The 
    following are among those NOT considered NIH employees: (a) Visiting 
    fellows (i.e. foreign scientists), (b) Intramural Research Training 
    Award (IRTA) recipients, (c) National Research Service Award (NRSA) 
    recipients, (d) Guest Researchers or Special Volunteers, (e) NIH-
    National Research Council (NRC) Biotechnology Research Associates 
    Program participants, and (f) Intergovernmental Personnel Act (IPA) 
    participants;
        (5) Participants may be appointed under a temporary or permanent 
    employment mechanism, so long as their employment in an LRC-approved 
    AIDS research assignment has the potential to last a minimum of 2 
    years;
        (6) Individuals with existing service obligations to Federal, 
    State, or other entities will not be considered for the Program unless 
    and until the existing service obligation is discharged or deferred for 
    the length of Program participation;
        (7) Applicants will not be excluded from consideration under the 
    Program on the basis of age, race, culture, religion, gender, 
    disability, or other non-merit factors.
    
    Additional Program Information
    
        This program is not subject to the provisions of Executive Order 
    12372, Intergovernmental Review of Federal Programs.
        This program is subject to OMB clearance under the requirements of 
    the Paperwork Reduction Act of 1980. A Request for OMB Review and 
    Approval of information collection associated with the program is being 
    prepared by the NIH.
        The Catalog of Federal Domestic Assistance number for the Program 
    is 93.936.
        Dated: June 17, 1994.
    Ruth L. Kirschstein,
    Deputy Director, NIH.
    [FR Doc. 94-23135 Filed 9-16-94; 8:45 am]
    BILLING CODE 4140-01-P
    
    
    

Document Information

Published:
09/19/1994
Entry Type:
Uncategorized Document
Action:
Notice.
Document Number:
94-23135
Dates:
Interested persons may request information about the Program beginning on September 19, 1994.
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: September 19, 1994, FR Doc. 94-23084 Filed 9-16-94, 8:45 am, FR Doc. 94-23135 Filed 9-16-94
RINs:
0905-ZA59